188 related articles for article (PubMed ID: 35700263)
21. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
[TBL] [Abstract][Full Text] [Related]
22. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
[TBL] [Abstract][Full Text] [Related]
23. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
24. Effect of NELL1 on lung cancer stem‑like cell differentiation.
Zhai Y; Wei R; Sha S; Lin C; Wang H; Jiang X; Liu G
Oncol Rep; 2019 Mar; 41(3):1817-1826. PubMed ID: 30628703
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
26. Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma.
Dai F; Luo F; Zhou R; Zhou Q; Xu J; Zhang Z; Xiao J; Song L
Aging (Albany NY); 2020 Jul; 12(14):14037-14049. PubMed ID: 32667904
[TBL] [Abstract][Full Text] [Related]
27. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
[TBL] [Abstract][Full Text] [Related]
28. The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling.
Hawkins AG; Basrur V; da Veiga Leprevost F; Pedersen E; Sperring C; Nesvizhskii AI; Lawlor ER
Mol Cell Proteomics; 2018 May; 17(5):901-912. PubMed ID: 29386236
[TBL] [Abstract][Full Text] [Related]
29. Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma.
Bai C; Yang M; Fan Z; Li S; Gao T; Fang Z
J Exp Clin Cancer Res; 2015 Jun; 34(1):58. PubMed ID: 26055407
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract][Full Text] [Related]
31. Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway.
Zhang D; Wang S; Chen J; Liu H; Lu J; Jiang H; Huang A; Chen Y
Int J Oncol; 2017 May; 50(5):1513-1530. PubMed ID: 28339091
[TBL] [Abstract][Full Text] [Related]
32. Delta-like Factor 1 as a Possible Therapeutic Target for Sarcomas.
Kim HS; Ahn SH; Kim HJ; Park JW; Han I
Clin Orthop Surg; 2020 Sep; 12(3):404-412. PubMed ID: 32904069
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
Jin Z; Mori Y; Yang J; Sato F; Ito T; Cheng Y; Paun B; Hamilton JP; Kan T; Olaru A; David S; Agarwal R; Abraham JM; Beer D; Montgomery E; Meltzer SJ
Oncogene; 2007 Sep; 26(43):6332-40. PubMed ID: 17452981
[TBL] [Abstract][Full Text] [Related]
34. Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2.
Yamamoto N; Kashiwagi M; Ishihara M; Kojima T; Maturana AD; Kuroda S; Niimi T
J Biol Chem; 2019 Mar; 294(12):4693-4703. PubMed ID: 30700556
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
36. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.
Hurley PJ; Hughes RM; Simons BW; Huang J; Miller RM; Shinder B; Haffner MC; Esopi D; Kimura Y; Jabbari J; Ross AE; Erho N; Vergara IA; Faraj SF; Davicioni E; Netto GJ; Yegnasubramanian S; An SS; Schaeffer EM
Cancer Res; 2015 Oct; 75(20):4322-34. PubMed ID: 26294211
[TBL] [Abstract][Full Text] [Related]
37. NELL1 promotes high-quality bone regeneration in rat femoral distraction osteogenesis model.
Xue J; Peng J; Yuan M; Wang A; Zhang L; Liu S; Fan M; Wang Y; Xu W; Ting K; Zhang X; Lu S
Bone; 2011 Mar; 48(3):485-95. PubMed ID: 20959151
[TBL] [Abstract][Full Text] [Related]
38. A calpain-6/YAP axis in sarcoma stem cells that drives the outgrowth of tumors and metastases.
Tchicaya-Bouanga J; Hung YJ; Schwartz JM; Yoon DJY; Chotard E; Marty C; Odri GA; de Pinieux G; Cohen-Solal M; Modrowski D
Cell Death Dis; 2022 Sep; 13(9):819. PubMed ID: 36153320
[TBL] [Abstract][Full Text] [Related]
39. NELL1 promotes bone regeneration in polyethylene particle-induced osteolysis.
Guo X; Peng J; Wang Y; Wang A; Zhang X; Yuan M; Zhang L; Zhao B; Liu B; Fan M; Xue J; Guo Q; Xu W; Lu Q; Ting K; Lu S
Tissue Eng Part A; 2012 Jul; 18(13-14):1344-51. PubMed ID: 22404332
[TBL] [Abstract][Full Text] [Related]
40. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
